5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT
5613260 一项 IIA-IIB 期、开放标签、单中心试验，旨在研究美金刚作为镰状细胞病患者长期支持治疗的安全性、耐受性和有效性：试验设计和入组
期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.709
Mo, Clifton C; Yee, Andrew J; Midha, Shonali; Hartley-Brown, Monique A; Nadeem, Omar; O'Donnell, Elizabeth K; Bianchi, Giada; Sperling, Adam S; Laubach, Jacob P; Richardson, Paul G; Yuh Lin, Adam; Cuttica, Michael J; Ison, Michael G; Gordon, Leo I; Levin, CL; Koren, AK; Peretz, SSP; Livshits, LL; Makhro, AM; Bogdanova, AB; Gassmann, MG
